Smarter Hematology through AI
Data You Can Trust. AI You Can Explain. Hematology You Can Advance.
Asian RWD, RWE based synthetic data and xAI development in Hematology
Explore our offerings
HemaCDS™
HemaCDS™ (Hematology Clinical Decision Support) assists hematologists in making effective clinical decisions
HPnote™
HPnote™ is a mobile software application developed for hematology patients receiving care from specialist hematologists in hospital settings.
eCRF™
The eCRF, developed through the collaboration of OmicSyn and JNPmedi, is a comprehensive electronic record form designed to streamline clinical trials for blood cancer. By minimizing the need for additional development, it enhances efficiency and standardization in data collection.
HRcds™
OmicSyn will provide information for news and products including PROs, Datasets, App, Database, AI, PCR kits and NGS panels, etc.
DASHBOARD
Over 5,000 Korean hematologic malignancy patient datasets will be available for further analysis on the MOTIE (Ministry of Trade, Industry and Energy) research platform under the secure environment of Naver Cloud. We are developing the central data creation tools where you can now explore data. This dashboard will soon show the dataset for participating hematologists and institutions. Please login to gain access and start exploring.
CML
New patient dataset (1200 patients) 2001~2021
KISS AI dataset (1200 patients) 2001~2021
New TKI dataset (1200 patients) 2001~2021
NGS dataset (1200 patients) 2001~2021
TFR dataset (295 patients) 2001~2021
MM
Coming soon
NHL
Coming soon
CML
MM
NHL
New patient dataset (1200 patients) 2001~2021
KISS AI dataset (1200 patients) 2001~2021
New TKI dataset (1200 patients) 2001~2021
NGS dataset (1200 patients) 2001~2021
TFR dataset (295 patients) 2001~2021
Coming soon
Coming soon
Our Partners in the BHIT industry
Mission
Partners
Commercial Products
Collect bio-bigdata & Generate xAI
App, databases, eHR, HemaCDS, CDMs & Cloud
Develop ELISA, NGS panels and ddPCR kits
Kits, Panels
Develop next-G TKIs, e.g. 5G TKIs etcs.
Next G-TKIs
Validate novel omics targets in Asian patients
Gene lists, hits validation
Conduct pre-clinical research
Lead compounds
Confirm omics targets through clinical trials
App, Database, eHR, HemaCDS, Kit & Drug
Operate and Maintain H-cloud
H-cloud services including data protection
*KoHeAD: Korea Hematology Alliance for biobigData)
a
*KoHeAD: Korea Hematology Alliance for biobigData)
a
a
*KoHeAD: Korea Hematology Alliance for biobigData)
